Primary information |
---|
ID | antitb_1814, |
Name | 23141114 |
N-Terminal modification | E6 (also called Sub3) |
C-Terminal Modification | RRWRIVVIRVRR |
Chemical Modification | Free |
Linear/Cyclic | Amidation |
Length | None |
Chirality | Linear |
Nature | 12 |
Source | L |
Origin | Cationic |
Species | Synthetic |
Inhibition Concentration | Mycobacterium tuberculosis |
In Vitro/ In vivo | Mycobacterium tuberculosis strain H37Rv |
Cell Line | MIC = 3.2 ± 0.10 g/mL |
Inhibition Concentration | Both |
Sequence | 2012 |
Cytotoxicity | NA |
In vivo Model | NA |
Lethal Dose | NA |
Immune Responce | Male BALB/c mice |
Mechanism of Action | a significant reduction in bacilli loads |
Target | NA |
Combination Therapy | Disruption of cell wall and membrane |
Other activities | cell wall and membrane |
PMID | NA |
Year of Publication | Antibacterial (P.aeruginosa) |
Tertiary Structure (Technique) | Not Predicted), |